Our immune system protects us but when it comes to some mosquito-borne disease, it can work against us. What are the implications for the development of a Zika virus vaccine?
Articles on Zika vaccine
Displaying all articles
In the future, consumers in the developed world could choose to purchase products from the companies that do the most to promote global health.
Public health experts enlist the molecular biology tools that create genetically modified organisms – as well as the GMOs themselves – in the fight against emerging infectious diseases.
During a disease outbreak, lots of people can become infected in a short time and develop immunity, making it hard for the pathogen to spread.
Recently two events concerning the Zika epidemic coincided: two potential vaccines against the virus were declared a success when used in mice, and Jason Day withdrew from the Olympic Games.
Top contributors
-
Clinical Associate Professor, School of Medical Science & Sydney Infectious Diseases Institute; Principal Hospital Scientist, University of Sydney
-
Professor in Mathematical Biology, The University of Melbourne
-
Professor of Philosophy, Binghamton University, State University of New York
-
Distinguished Professor, Public Health and Medical Anthropology, University of the Witwatersrand
-
Associate Professor, Computing & Information Systems; Director, Melbourne Data Analytics Platform, The University of Melbourne
-
Lecturer (University of Tasmania), University of Tasmania
-
Laboratory Head, Department of Microbiology and Immunology, The University of Melbourne
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Ph.D. Candidate in Chemical Biology, Harvard University
-
Head of School of Population Health and Professor, Infectious Diseases Dynamics and Interventions, UNSW